Washington Times: Johnson & Johnson one-shot coronavirus vaccine endorsed by FDA advisers
Sarah Christopherson, a policy advocacy director at the National Women’s Health Network, said the J&J vaccine will improve access and save lives but people might need help in understanding its strengths versus vaccines that were tested and approved weeks ago.
“There is a significant concern that headline numbers are already leading to a sense among the public there are first- and second-class vaccines, with the latter relegated to low-income, rural or otherwise marginalized communities. That has the potential to exacerbate public mistrust. Public health authorities must address these perceptions head-on,” she told the FDA’s Vaccines and Related Biological Products Advisory Committee, or VRBPAC.
